830 U.S. Multicenter Pilot Study of Daily Consensus Interferon (Infergen) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 Patients: Final Results

Samuel B. Ho; Eric Dieperink; Bashar Aqel; Shanglei Liu; Lori Tetrick; Yngve Falck–Ytter; Charles DeComarmond; Coleman I. Smith; Daniel P. McKee; Anastasios A. Mihas

doi:10.1016/s0016-5085(09)63733-1

830 U.S. Multicenter Pilot Study of Daily Consensus Interferon (Infergen) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 Patients: Final Results

Identifier:nobleid.org/w1/20260515/3B3DF6AF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3B3DF6AF.svg?ark=w1%2F20260515%2F3B3DF6AF)](https://nobleid.org/work/w1/20260515/3B3DF6AF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

830 U.S. Multicenter Pilot Study of Daily Consensus Interferon (Infergen) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 Patients: Final Results

Identifier:nobleid.org/w1/20260515/3B3DF6AF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3B3DF6AF.svg?ark=w1%2F20260515%2F3B3DF6AF)](https://nobleid.org/work/w1/20260515/3B3DF6AF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work